Carbonic anhydrase — the key of anti-aging

Scientists at the University of Nottingham recently discovered a protein called carbonic anhydrase in energetic cells, which may be a key factor in slowing aging. The findings also provide a direction for scientists to look for drugs that remove the body’s aging effects.

The study was published in the academic journal Aging. This study using recombinant horse proteins plays an important role in the treatment of senescence-related diseases and slows down the aging process, such as neurodegenerative diseases — Parkinson’s syndrome and Alzheimer’s disease. The researchers found carbonic anhydrase in the mitochondria of cells. Mitochondria are the places where cells consume oxygen to produce energy (ATP) for human activity.

Researcher Dr. Chakrabarti said, “What really excited us in this study is that we hypothesize that this protein plays an important role in cellular senescence. It suggests how we can slow down the aging process of our body through mitochondrial carbonic anhydrase and opens up new treatment pathway for other aging-related diseases.

The researchers isolated and compared carbonic anhydrase from the mitochondria of brain cells in the brains of normal young adults and normal middle-aged men. The results showed that brain cells carbonic anhydrase levels of middle-aged people are much higher than that of young people. In addition, in early populations with neurodegenerative diseases, the level of carbonic anhydrase is also high. Thus, elevated levels of carbonic anhydrase are harmful, and they are closely related to aging.

With age, the function of body tissue begins to weaken. At about 50 years of age, the process of aging is accompanied by a reduction in muscle mass. In the early sixties, the muscle reduces more rapidly. The aging of the brain leads to cognitive decline, affecting memory, ability to respond and a variety of skills and finally leading to dementia. Flarebio provides superior recombinant proteins such as recombinant ECE1 at good prices.